celastrol has been researched along with Allodynia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Feng, M; Li, J; Wan, L; Yao, W; Zhang, B; Zhang, C; Zhang, Y | 1 |
| Huang, C; Huang, Z; Liu, X; Shan, R; Zhang, X; Zhao, W | 1 |
| Fu, J; Li, Y; Lin, D; Qiu, Y; Ren, J; Yang, L; Zhu, C | 1 |
3 other study(ies) available for celastrol and Allodynia
| Article | Year |
|---|---|
Celastrol attenuates incision-induced inflammation and pain associated with inhibition of the NF-κB signalling pathway via SARM.
Topics: Animals; Armadillo Domain Proteins; Cytokines; Cytoskeletal Proteins; Hyperalgesia; Inflammation; Macrophages; Male; NF-kappa B; Pain; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Transcription Factor RelA; Triterpenes; Wounds and Injuries | 2018 |
Celastrol ameliorates inflammatory pain and modulates HMGB1/NF-κB signaling pathway in dorsal root ganglion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Freund's Adjuvant; Ganglia, Spinal; HMGB1 Protein; Hyperalgesia; Inflammation; Inflammation Mediators; Male; NF-kappa B; Pain; Pentacyclic Triterpenes; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Triterpenes | 2019 |
Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.
Topics: Analgesics; Animals; Camphanes; Carrageenan; Disease Models, Animal; Edema; Hyperalgesia; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred C57BL; Neuralgia; Pentacyclic Triterpenes; Pyrazoles; Receptor, Cannabinoid, CB2; Signal Transduction; Spinal Cord Injuries; Tripterygium; Triterpenes; Tumor Necrosis Factor-alpha | 2014 |